COVID-19 Vaccine Acceptance in Pregnant Women
Şerife Ayhan, D. Oluklu, A. Atalay, D.M. Beser, A. Tanacan, O.M. Tekin, Dr Ugur Sahin
Abstract
( Int J Gynecol Obstet . 2021;154:291–296) In the time since the SARS-CoV-2 pandemic began in 2020, over 5 million deaths worldwide have been attributed to the disease, COVID-19, which the SARS-COV-2 virus causes. Pregnant women who contract COVID-19 have been shown in studies to be 20 times more likely to die of complications from the disease than their pregnant peers who do not contract COVID-19. Infected pregnant women are much more likely to develop preeclampsia, experience preterm birth, require intubation, and stay in an ICU setting. They are at higher risk for severe disease than both their noninfected pregnant peers and their nonpregnant infected peers. Although new treatments for COVID-19 are emerging, the best way for pregnant women to protect themselves and their unborn baby from the effects of COVID-19 is through vaccination. Vaccination for COVID-19 has been shown to strengthen an individual’s immune response and decrease the severity of the disease in infected individuals.